Novel Interferons for Treatment of Hepatitis C Virus
- 31 August 2009
- journal article
- review article
- Published by Elsevier BV in Clinics in Liver Disease
- Vol. 13 (3), 351-363
- https://doi.org/10.1016/j.cld.2009.05.004
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionThe New England Journal of Medicine, 2009
- Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus ReplicationOnline Journal of Public Health Informatics, 2008
- Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and RibavirinDigestive Diseases and Sciences, 2008
- Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseasesProceedings of the National Academy of Sciences of the United States of America, 2007
- Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and RibavirinDigestive Diseases and Sciences, 2007
- A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsJournal of Hepatology, 2006
- Pilot study of interferon gamma for chronic hepatitis CJournal of Hepatology, 2005
- The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis CJournal of Hepatology, 2004
- Open-label study of omega interferon in previously untreated HCV-infected patientsJournal of Hepatology, 2002
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonThe New England Journal of Medicine, 1986